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Background
Advanced glycation end products (AGEs) are formed due
to hyperglycemia in T2DM. Interaction of AGEs with its
receptor RAGE induces signal transduction that culmi-
nates in vascular complications, the major cause of mor-
bidity and mortality in diabetic subjects. Some functional
polymorphism of this gene show differential activity of this
receptor and therefore may be associated with the devel-
opment of diabetic complications. In the present study we
investigated the association of expression of RAGE gene
and its polymorphism namely -374T/A and -429T/C in
the promoter region and Gly82Ser polymorphism in the
exon 3 region with vascular complications in T2DM
patients.
Materials and methods
We screened 820 subjects which includes 200 healthy con-
trols, 200 type 2 diabetes mellitus (T2DM) subjects without
any vascular complications (DM), 220 T2DM subjects with
microvascular complications (DM-Micro) and 200 T2DM
subjects with macrovascular complications (DM-Macro)
for -374 T/A, -429 T/C and Gly82Ser polymorphisms of
RAGE gene. DNA isolated from the enrolled subjects was
genotyped by PCR-RFLP. RAGE expression was deter-
mined by quantitative real-time PCR.
Results
Mutant variant of -429T/C and Gly82Ser RAGE poly-
morphism was about three times more prone to develop
macrovascular and microvascular complications respec-
tively in T2DM subjects while -374A allele showed reduced
risk towards the development of macrovascular complica-
tions (OR = 0.57, p = 0.006). Further, haplotype analysis
revealed that CTG haplotype was significantly associated
with the development of macrovascular complications
while haplotype TAG was observed to be significantly
protective towards development of macrovascular compli-
cations in T2DM subjects. The expression of RAGE corre-
lated significantly with the genotypic variation of the
RAGE gene.
Conclusions
Mutant genotypes of RAGE gene and its enhanced
expression may be considered as risk factor for vascular
complications in North Indian T2DM patients.
Published: 21 January 2014
doi:10.1186/1755-8166-7-S1-P29
Cite this article as: Chawla et al.: RAGE gene polymorphism and
expression: risk factor for vascular complications in type 2 diabetes
mellitus. Molecular Cytogenetics 2014 7(Suppl 1):P29.
* Correspondence: aktripathiucms@gmail.com
Department of Biochemistry and Department of Medicine, University College
of Medical Sciences and G.T.B. Hospital, Delhi-110095, India
Chawla et al. Molecular Cytogenetics 2014, 7(Suppl 1):P29
http://www.molecularcytogenetics.org/content/7/S1/P29
© 2014 Chawla et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
